Colgate-Palmolive Co. (NYSE:CL) finished Friday with a subtraction of -$0.2 to close at $71.11, a downside of -0.28 percent. An average of 3,449,740 shares of common stock have been traded in the last five days. There was a fall of -$1.34 in the past week, and it reached a new high 24 times over the past 12 months. The last 20 days have seen an average of 3,644,415 shares traded, while the 50-day average volume stands at 4,052,502.
CL stock has decreased by -3.71% in the last month. The company shares reached their 1-month lowest point of $70.72 on 09/29/23. With the stock rallying to its 52-week high on 05/15/23, shares of the company touched a low of $67.84 and a high of $82.09 in 52 weeks. It has reached a new high 7 times so far this year and lost -9.75% or -$7.68 in price. In spite of this, the price is down -13.38% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CL stock investors should be aware that Colgate-Palmolive Co. (CL) stock had its last reported insider trading activity 19 days ago on Sep 11. In this transaction, the insider spent $3,567,982. CLO and Secretary, Daniels Jennifer, disposed of 24,704 shares at a price of $73.31 on Sep 11. The insider now owns more than $1,811,016 worth of shares. Prior to that, Vice President and Controller Malcolm Gregory went on to Sale 10,493 shares at $73.90 each on Aug 31. An amount of $775,457 was transacted.
Valuation Metrics
Colgate-Palmolive Co. (CL) has a trailing price-to-earnings (P/E) ratio of 39.65. The stock’s beta is 0.49. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.15, and the price-to-cash flow ratio at 24.95.
Financial Health
The quick ratio of Colgate-Palmolive Co. for the three months ended June 29 was 0.73, and the current ratio was 1.17, indicating that the company is not able to meet its debt obligations. Its gross profit as reported stood at $10.25 billion compared to revenue of $17.97 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Colgate-Palmolive Co.’s return on assets was 9.37%.
Earnings Surprise
For the three-month period that ended June 29, Colgate-Palmolive Co. had $8.95 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $502.0 million in the quarter, while revenues were shrunk -20.12%. The analyst consensus anticipated Colgate-Palmolive Co.’s latest quarter earnings to come in at $0.75 per share, but it turned out to be $0.77, a 2.70% surprise. For the quarter, EBITDA amounted to $1.12 billion. Shareholders own equity worth $826.69 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Colgate-Palmolive Co. (CL) price momentum. RSI 9-day as of the close on 29 September was 31.91%, suggesting the stock is Neutral, with historical volatility in this time frame at 9.30%.
As of today, CL’s price is $71.54 -1.85% or -$1.34 from its 5-day moving average. CL is currently trading -3.21% lower than its 20-day SMA and -11.94% lower than its 100-day SMA. However, the stock’s current price level is -7.65% below the SMA50 and -9.54% below the SMA200.
The stochastic %K and %D were 11.04% and 10.00%, respectively, and the average true range (ATR) was 0.98. With the 14-day stochastic at 11.37% and the average true range at 0.99, the RSI (14) stands at 35.35%. The stock has reached -1.10 on the 9-day MACD Oscillator while the 14-day reading was at -1.43.
Analyst Ratings
HSBC Securities launched coverage on Colgate-Palmolive Co. (NYSE: CL) in its analyst report released on September 22, 2023. The firm assigned the stock a Buy rating. The consensus rating for Colgate-Palmolive Co. (CL) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CL, while 12 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 10 others rate it as a “buy”.
What is CL’s price target for the next 12 months?
Analysts predict a range of price targets between $68.00 and $98.00, with a median target of $85.00. Taking a look at these predictions, the average price target given by analysts for Colgate-Palmolive Co. (CL) stock is $84.93.
